The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases

The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases

Spleen tyrosine kinase (SYK) is an enigmatic protein tyrosine kinase, and involved in signal transduction related with lots of cellular processes. It’s highly expressed in the cells of hematopoietic origin and acts as an important therapeutic target in the treatment of autoimmune diseases and allerg...

書誌詳細
主要な著者:	Yaping Zhao, Rongrong Liu, Miaomiao Li, Pengfei Liu
フォーマット:	論文
言語:	English
出版事項:	Elsevier 2022-12-01
シリーズ:	Heliyon
主題:	Spleen tyrosine kinase (SYK) Liver diseases Small molecule inhibitor Therapy target
オンライン･アクセス:	http://www.sciencedirect.com/science/article/pii/S2405844022034181

類似資料

The selective inhibition of the Syk tyrosine kinase ameliorates experimental autoimmune arthritis
著者:: Eszter Káposztás, 等
出版事項: (2023-12-01)

Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib
著者:: Nichola Cooper, 等
出版事項: (2023-01-01)

Biochemical characterization of spleen tyrosine kinase (SYK) isoforms in platelets
著者:: Pankaj Kumar Singh, 等
出版事項: (2023-12-01)

Activation of spleen tyrosine kinase (SYK) contributes to neuronal pyroptosis and cognitive impairment in diabetic mice via the NLRP3/Caspase-1/GSDMD signaling pathway
著者:: Chenglong Zhou, 等
出版事項: (2024-12-01)

Identification of high-performing antibodies for tyrosine-protein kinase SYK for use in Western Blot, immunoprecipitation and immunofluorescence [version 3; peer review: 2 approved]
著者:: Carl Laflamme, 等
出版事項: (2024-06-01)

Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice
著者:: Dániel Csete, 等
出版事項: (2019-04-01)

Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
著者:: Mohan Li, 等
出版事項: (2023-05-01)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
著者:: Ryunosuke Muro, 等
出版事項: (2023-01-01)

Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis
著者:: Christopher W. Pohlmeyer, 等
出版事項: (2021-03-01)

Anti-microbial cetylpyridinium chloride suppresses mast cell function by targeting tyrosine phosphorylation of Syk kinase
著者:: Bright Obeng, 等
出版事項: (2024-12-01)

Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
著者:: Kata P. Szilveszter, 等
出版事項: (2019-08-01)

S-Layer From Lactobacillus brevis Modulates Antigen-Presenting Cell Functions via the Mincle-Syk-Card9 Axis
著者:: Mariano Prado Acosta, 等
出版事項: (2021-03-01)

A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells
著者:: Hyang‑Hee Seo, 等

Spleen Tyrosine Kinase Is a Critical Regulator of Neutrophil Responses to <italic toggle="yes">Candida</italic> Species
著者:: Paige E. Negoro, 等
出版事項: (2020-06-01)

Immunomodulatory role of spleen tyrosine kinase in chronic inflammatory and autoimmune diseases
著者:: Yaqi Zhou, 等
出版事項: (2023-07-01)

CCL4‐mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease
著者:: Wenbin Gong, 等
出版事項: (2021-02-01)

Inhibition of Spleen Tyrosine Kinase Restores Glucocorticoid Sensitivity to Improve Steroid-Resistant Asthma
著者:: Qian Liu, 等
出版事項: (2022-05-01)

Systematic analysis of spleen tyrosine kinase expression and its clinical outcomes in various cancers
著者:: Akram I Alwithenani, 等
出版事項: (2020-01-01)

Phosphorylation of (Ser 291) in the linker insert of Syk negatively regulates ITAM signaling in platelets
著者:: Carol Dangelmaier, 等
出版事項: (2024-12-01)

The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients
著者:: Jing Wang, 等
出版事項: (2023-02-01)

Expression of variant isoforms of the tyrosine kinase SYK differentially regulates cervical cancer progression through PI3K/AKT pathway
著者:: Bingjie Lin, 等
出版事項: (2024-11-01)

Three Novel Players: PTK2B, SYK, and TNFRSF21 Were Identified to Be Involved in the Regulation of Bovine Mastitis Susceptibility via GWAS and Post-transcriptional Analysis
著者:: Fan Yang, 等
出版事項: (2019-08-01)

Development of SYK NanoBRET cellular target engagement assays for gain–of–function variants
著者:: Jacob L. Capener, 等
出版事項: (2024-07-01)

Effects of a spleen tyrosine kinase inhibitor on progression of the lupus nephritis in mice
著者:: Maki Kitai, 等
出版事項: (2017-05-01)

Mechanisms of acquired resistance to tyrosine kinase inhibitors
著者:: Yi-fan Chen, 等
出版事項: (2011-12-01)

Tyrosine kinase targeting: A potential therapeutic strategy for diabetes
著者:: Mohammad Althubiti
出版事項: (2022-01-01)

Spleen tyrosine kinase inhibitors disrupt human neutrophil swarming and antifungal functions
著者:: Alex Hopke, 等
出版事項: (2025-01-01)

Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease
著者:: Soumitra Ghosh, 等
出版事項: (2015-11-01)

Fluorescent Tracking of Yeast Division Clarifies the Essential Role of Spleen Tyrosine Kinase in the Intracellular Control of Candida glabrata in Macrophages
著者:: Zeina Dagher, 等
出版事項: (2018-05-01)

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer
著者:: Chen-Yu Hu, 等
出版事項: (2019-12-01)

Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies
著者:: Xuejin Ou, 等
出版事項: (2024-09-01)

Inhibitory effects of regorafenib, a multiple tyrosine kinase inhibitor, on corneal neovascularization
著者:: Halil Ibrahim Onder, 等
出版事項: (2014-04-01)

Receptor Tyrosine Kinase Signaling Involves <i>Echinococcus</i>–Host Intercommunication: A Potential Therapeutic Target in Hepatic Echinococcosis
著者:: Haijun Gao, 等
出版事項: (2024-08-01)

Advances in studies of tyrosine kinase inhibitors and their acquired resistance
著者:: Qinlian Jiao, 等
出版事項: (2018-02-01)

Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
著者:: Sareshma Sudhesh Dev, 等
出版事項: (2021-11-01)

Exploring receptor tyrosine kinases-inhibitors in Cancer treatments
著者:: D. Samuel Metibemu, 等
出版事項: (2019-12-01)

Recent developments in receptor tyrosine kinases targeted anticancer therapy
著者:: Samir H. Raval, 等
出版事項: (2016-01-01)

Complement receptor-3 negatively regulates the phagocytosis of degenerated myelin through tyrosine kinase Syk and cofilin
著者:: Hadas Smadar, 等
出版事項: (2012-07-01)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
著者:: Xu H, 等
出版事項: (2019-07-01)

Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma
著者:: Ming Zeng, 等
出版事項: (2024-03-01)